Glucose Transporter Type 1

"Glucose Transporter Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A ubiquitously expressed glucose transporter that is important for constitutive, basal GLUCOSE transport. It is predominately expressed in ENDOTHELIAL CELLS and ERYTHROCYTES at the BLOOD-BRAIN BARRIER and is responsible for GLUCOSE entry into the BRAIN.

Descriptor ID	D051272
MeSH Number(s)	D12.776.157.530.500.500.500 D12.776.157.530.937.563.500 D12.776.543.585.500.500.500 D12.776.543.585.937.625.500
Concept/Terms	Glucose Transporter Type 1 Glucose Transporter Type 1 GLUT-1 Protein GLUT 1 Protein Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1 Protein SLC2A1 Protein GLUT1 Protein Erythrocyte Glucose Transporter Glucose Transporter, Erythrocyte

Below are MeSH descriptors whose meaning is more general than "Glucose Transporter Type 1".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Membrane Transport Proteins [D12.776.157.530]
Monosaccharide Transport Proteins [D12.776.157.530.500]
Glucose Transport Proteins, Facilitative [D12.776.157.530.500.500]
Glucose Transporter Type 1 [D12.776.157.530.500.500.500]
Solute Carrier Proteins [D12.776.157.530.937]
Glucose Transport Proteins, Facilitative [D12.776.157.530.937.563]
Glucose Transporter Type 1 [D12.776.157.530.937.563.500]
Membrane Proteins [D12.776.543]
Membrane Transport Proteins [D12.776.543.585]
Monosaccharide Transport Proteins [D12.776.543.585.500]
Glucose Transport Proteins, Facilitative [D12.776.543.585.500.500]
Glucose Transporter Type 1 [D12.776.543.585.500.500.500]
Solute Carrier Proteins [D12.776.543.585.937]
Glucose Transport Proteins, Facilitative [D12.776.543.585.937.625]
Glucose Transporter Type 1 [D12.776.543.585.937.625.500]

Below are MeSH descriptors whose meaning is related to "Glucose Transporter Type 1".

Below are MeSH descriptors whose meaning is more specific than "Glucose Transporter Type 1".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glucose Transporter Type 1" by people in this website by year, and whether "Glucose Transporter Type 1" was a major or minor topic of these publications.

Bar chart showing 15 publications over 9 distinct years, with a maximum of 3 publications in 2009 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2006	1	0	1
2009	1	2	3
2010	0	1	1
2011	0	2	2
2016	1	1	2
2017	0	1	1
2019	1	0	1
2020	1	2	3

Below are the most recent publications written about "Glucose Transporter Type 1" by people in Profiles.

Tilekar K, Upadhyay N, Schweipert M, Hess JD, Macias LH, Mrowka P, Meyer-Almes FJ, Aguilera RJ, Iancu CV, Choe JY, Ramaa CS. Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells. Eur J Pharm Sci. 2020 Nov 01; 154:105512.

View in: PubMed
Tilekar K, Upadhyay N, Hess JD, Macias LH, Mrowka P, Aguilera RJ, Meyer-Almes FJ, Iancu CV, Choe JY, Ramaa CS. Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential. Eur J Med Chem. 2020 Sep 15; 202:112603.

View in: PubMed
Upadhyay N, Tilekar K, J?nsch N, Schweipert M, Hess JD, Henze Macias L, Mrowka P, Aguilera RJ, Choe JY, Meyer-Almes FJ, Ramaa CS. Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation. Bioorg Chem. 2020 07; 100:103934.

View in: PubMed
Chen LY, Phelix CF. Extracellular gating of glucose transport through GLUT 1. Biochem Biophys Res Commun. 2019 04 09; 511(3):573-578.

View in: PubMed
Pereira PMR, Berisha N, Bhupathiraju NVSDK, Fernandes R, Tom? JPC, Drain CM. Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers. PLoS One. 2017; 12(5):e0177737.

View in: PubMed
Fernandez AM, Hernandez-Garz?n E, Perez-Domper P, Perez-Alvarez A, Mederos S, Matsui T, Santi A, Trueba-Saiz A, Garc?a-Guerra L, Pose-Utrilla J, Fielitz J, Olson EN, Fernandez de la Rosa R, Garcia Garcia L, Pozo MA, Iglesias T, Araque A, Soya H, Perea G, Martin ED, Torres Aleman I. Insulin Regulates Astrocytic Glucose Handling Through Cooperation With IGF-I. Diabetes. 2017 Jan; 66(1):64-74.

View in: PubMed
Noguchi C, Kamitori K, Hossain A, Hoshikawa H, Katagi A, Dong Y, Sui L, Tokuda M, Yamaguchi F. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression. Tohoku J Exp Med. 2016 02; 238(2):131-41.

View in: PubMed
Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Rom?n-P?rez E, D'Arcy M, Freemerman AJ, Perou CM, Troester MA. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res. 2013 Feb 01; 19(3):571-85.

View in: PubMed
Belkacemi L, Jelks A, Chen CH, Ross MG, Desai M. Altered placental development in undernourished rats: role of maternal glucocorticoids. Reprod Biol Endocrinol. 2011 Aug 01; 9:105.

View in: PubMed
Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, Kramer PL, Schneider JA, Bennett DA, Feany MB, De Jager PL. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals